Abstract: Monitoring vaccine safety through the Vaccine Adverse Event Reporting System (VAERS) is often hindered by a lack of individual-level demographic data due to privacy protections. This study introduces a novel statistical framework that integrates VAERS data with U.S. Census and CDC survey data to infer racial and ethnic disparities in adverse event (AE) reporting rates. By leveraging geographic variation across U.S. states, the researchers identified nine specific AEs for the HPV vaccine with significant reporting differences between non-Hispanic White females and other groups, offering a privacy-preserving method for enhanced pharmacovigilance.
Introduction
The Vaccine Adverse Event Reporting System (VAERS) is a cornerstone of post-market vaccine safety monitoring in the United States. However, to protect patient privacy, individual-level demographics such as race and ethnicity are often omitted or limited. This creates a significant gap in understanding how vaccine safety profiles might differ across diverse populations—a critical concern given that immune responses can vary based on genetic and ethnic backgrounds. This study sought to bridge this gap by integrating disparate data sources to detect population-level associations.
Methodology: Data Integration and Modeling
The researchers developed a generalized linear mixed effects model that uses U.S. states as the primary unit of analysis. By correlating state-level demographic distributions with state-level vaccine adverse event reporting rates, the model can infer associations that are missing at the individual level.
The study integrated four primary datasets from 2010 to 2016:
- VAERS: Reports of serious AEs following HPV vaccination.
- CDC NIS-Teen: Survey data providing state-level HPV vaccine coverage rates.
- U.S. Census Bureau: Annual population estimates for demographic distribution.
- MedDRA: Standardized coding for 2,864 unique adverse event "Preferred Terms."
Because serious adverse events are rare, the resulting dataset was highly sparse (99.2% zeros). To address this, the team employed a Zero-Inflated Poisson (ZIP) regression model, which specifically accounts for the high frequency of zero-report data points that would otherwise skew standard regression results.
Key Results: Identifying Disparities
After analyzing nearly 3,000 unique adverse event terms and applying a rigorous Bonferroni correction for multiple testing, the study identified nine adverse events with significantly different reporting rates between non-Hispanic White females and other race/ethnicity groups.
Significant findings included:
- Higher reporting rates in non-Hispanic White females: Vulvovaginal pain, vulvovaginal rash, lichen sclerosus (potentially related to autoimmune responses), ECG changes, and tension headaches.
- Lower reporting rates in non-Hispanic White females (Higher in other groups): Fecal incontinence, absent pulse (potentially related to cardiovascular issues), bedridden status, and abnormal respiration.
Discussion and Limitations
This geographic proxy method demonstrates a powerful way to conduct sensitive demographic research without compromising individual privacy. However, the authors note several limitations. The "ecological fallacy" remains a risk; population-level associations do not necessarily dictate individual outcomes. Furthermore, the model assumes constant reporting rates across groups, which may not account for cultural or socioeconomic differences in how symptoms are reported.
Future work may involve applying this framework to other vaccines, such as influenza, and refining models to better account for potential reporting biases between different demographic groups.
Summary updated